C5AR1 and neoplasm: Most previous studies showing tumor-promoting effects of complement C3a and/or C5a have utilized tumor models syngeneic in C57Bl/6 mice whose immune system is skewed towards a Th1-M1 response [24,25,26,27,28,57].